Halozyme Therapeutics, Inc. (HALO)
125.63
+1.09
(+0.88%)
USD |
NASDAQ |
Oct 23, 16:00
125.59
-0.04
(-0.03%)
After-Hours: 20:00
Halozyme Therapeutics Price : 125.63 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 124.54 | 126.23 | 123.74 | 125.63 | 1.530M |
| Oct 22, 2026 | 124.72 | 124.91 | 121.62 | 124.54 | 5.098M |
| Oct 21, 2026 | 123.90 | 125.43 | 122.71 | 124.83 | 1.716M |
| Oct 20, 2026 | 123.54 | 125.10 | 123.00 | 124.37 | 2.149M |
| Oct 19, 2026 | 121.72 | 123.60 | 121.68 | 122.50 | 1.894M |
| Oct 16, 2026 | 122.19 | 122.44 | 120.19 | 121.84 | 2.083M |
| Oct 15, 2026 | 118.35 | 122.33 | 117.38 | 121.51 | 2.470M |
| Oct 14, 2026 | 109.90 | 119.21 | 109.42 | 116.82 | 3.770M |
| Oct 13, 2026 | 111.92 | 111.92 | 108.80 | 109.62 | 1.773M |
| Oct 12, 2026 | 110.19 | 112.43 | 109.96 | 111.08 | 1.660M |
| Oct 09, 2026 | 109.70 | 112.65 | 109.70 | 110.42 | 1.845M |
| Oct 08, 2026 | 109.41 | 110.64 | 107.41 | 109.84 | 2.490M |
| Oct 07, 2026 | 111.62 | 114.00 | 110.16 | 110.79 | 2.179M |
| Oct 06, 2026 | 108.87 | 111.24 | 107.43 | 109.72 | 1.774M |
| Oct 05, 2026 | 109.62 | 109.87 | 107.68 | 108.31 | 1.856M |
| Oct 02, 2026 | 106.96 | 109.99 | 106.65 | 109.86 | 2.600M |
| Oct 01, 2026 | 109.93 | 110.50 | 106.84 | 106.94 | 2.329M |
| Sep 30, 2026 | 111.54 | 112.45 | 110.35 | 110.40 | 3.521M |
| Sep 29, 2026 | 112.89 | 114.52 | 111.03 | 111.56 | 2.873M |
| Sep 28, 2026 | 113.34 | 113.94 | 112.10 | 112.89 | 2.237M |
| Sep 25, 2026 | 115.36 | 115.62 | 113.43 | 113.90 | 1.958M |
| Sep 24, 2026 | 112.13 | 116.09 | 111.07 | 115.22 | 3.172M |
| Sep 23, 2026 | 116.84 | 116.84 | 112.18 | 112.44 | 2.703M |
| Sep 22, 2026 | 111.50 | 115.18 | 110.95 | 115.13 | 4.152M |
| Sep 21, 2026 | 112.80 | 113.47 | 111.05 | 111.45 | 2.877M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AVITA Medical, Inc. | 15.51 |
| Iovance Biotherapeutics, Inc. | 14.09 |
| Merck & Co., Inc. | 145.27 |
| Agenus, Inc. | 6.33 |
| Amgen, Inc. | 439.26 |
Price Related Metrics
| PE Ratio | 37.54 |
| PS Ratio | 9.138 |
| Price to Book Value | 99.81 |
| Price to Free Cash Flow | 18.86 |
| Earnings Yield | 2.66% |
| Market Cap | 14.33B |
| Operating PE Ratio | 16.10 |
| Normalized PE Ratio | 23.07 |